tiprankstipranks

Axel Bolte Insider Profile

11 Followers
Axel Bolte, Director at IVERIC bio, holds 0.00 shares in IVERIC bio (Ticker: ISEE), holds ― shares in Nabriva Therapeutics (Ticker: NBRVF), holds ― shares in Allena Pharmaceuticals (Ticker: ALNAQ).
tipranks
Axel Bolte

Axel Bolte
IVERIC bio (ISEE)
Director

Ranked #63,077 out of 98,501 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

-8.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
71.21%
28.79%
0.00%
A breakdown of Axel Bolte's holdings

Insider Roles

Inozyme Pharma
(INZY)
Director
PTC Therapeutics
(PTCT)
Director
Nabriva Therapeutics
(NBRVF)
Director
Roles that Axel Bolte holds in companies

Most Profitable Insider Trade

Stock:
Inozyme Pharma
(INZY)
Rating:Informative Buy
Date:Apr 20, 2022 - Apr 20, 2023
Return:+30.30%
The most profitable trade made by Axel Bolte

Axel Bolte's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ISEE
IVERIC bio
Jul 13, 2023
Uninformative Sell
$0.00
Nabriva Therapeutics
Director
ALNAQ
Allena Pharmaceuticals
Inozyme Pharma
Apr 04, 2023
Director
Uninformative Buy
10.62K
$1.22M
PTC Therapeutics
Jun 27, 2013
Director
Informative Buy
300.00K
$493.80K
List of latest transactions for each holding click on a transaction to see Axel Bolte's performance on stock

Axel Bolte insider profile FAQ

What is the percentage of profitable transactions made by Axel Bolte?
The percentage of profitable transactions made by Axel Bolte is 50%.
    What is the average return per transaction made by Axel Bolte?
    The average return per transaction made by Axel Bolte is -8.90%.
      What stocks does Axel Bolte hold?
      Axel Bolte holds: ISEE, NBRVF, ALNAQ, INZY, PTCT stocks.
        What was Axel Bolte’s latest transaction?
        Axel Bolte latest transaction was an Uninformative Sell of ―.
          What was Axel Bolte's most profitable transaction?
          Axel Bolte’s most profitable transaction was an Informative Buy of INZY stock on April 20, 2022. The return on the trade was 30.30%.
            What is Axel Bolte's role in IVERIC bio?
            Axel Bolte's role in IVERIC bio is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.